Hrt Financial LP Vyne Therapeutics Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.37 - $0.71 $6,054 - $11,618
-16,364 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.5 - $1.15 $8,182 - $18,818
16,364 New
16,364 $10,000
Q4 2021

Feb 14, 2022
SELL
$0.91 - $1.5 $70,994 - $117,024
-78,016 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$1.39 - $3.47 $36,584 - $91,330
-26,320 Reduced 25.23%
78,016 $108,000
Q2 2021

Aug 16, 2021
BUY
$3.24 - $6.92 $338,048 - $722,005
104,336 New
104,336 $366,000

Others Institutions Holding VYNE

# of Institutions
2
Shares Held
36.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $176M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email